The Impact of COVID-19 is included in Cloning and Mutagenesis Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Cloning and Mutagenesis Trends and Forecast
The future of the global cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets. The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030 with a CAGR of 18.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cloning and Mutagenesis by Segment
The study includes a forecast for the global cloning and mutagenesis by product, technology, end use, and region.
Cloning and Mutagenesis Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Cloning Kits
• Mutagenesis Kits
• Others
Cloning and Mutagenesis Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
• Topo PCR Cloning
• Blunt end Cloning
• Seamless Cloning
• Others
Cloning and Mutagenesis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Biopharmaceutical & Pharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes
Cloning and Mutagenesis Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Cloning and Mutagenesis Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cloning and mutagenesis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cloning and mutagenesis companies profiled in this report include-
• Takara Bio
• Agilent Technologies
• Thermo Fisher Scientific
• New England Biolabs
• Merck
• Promega
• Bio-Rad Laboratories
• Danaher
• Jena Bioscience
• Assay Genie
Cloning and Mutagenesis Market Insights
Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.
Within this market, biopharmaceutical & pharmaceutical companies will remain the largest segment due to increasing prevalence of diseases.
North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.
Features of the Global Cloning and Mutagenesis Market
Market Size Estimates: Cloning and mutagenesis market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cloning and mutagenesis market size by product, technology, end use, and region in terms of value ($B).
Regional Analysis: Cloning and mutagenesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, technologies, end uses, and regions for the cloning and mutagenesis market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cloning and mutagenesis market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the cloning and mutagenesis market size?
Answer: The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030.
Q.2 What is the growth forecast for cloning and mutagenesis market?
Answer: The global cloning and mutagenesis market is expected to grow with a CAGR of 18.0% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the cloning and mutagenesis market?
Answer: The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.
Q4. What are the major segments for cloning and mutagenesis market?
Answer: The future of the cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets.
Q5. Who are the key cloning and mutagenesis market companies?
Answer: Some of the key cloning and mutagenesis companies are as follows:
• Takara Bio
• Agilent Technologies
• Thermo Fisher Scientific
• New England Biolabs
• Merck
• Promega
• Bio-Rad Laboratories
• Danaher
• Jena Bioscience
• Assay Genie
Q6. Which cloning and mutagenesis market segment will be the largest in future?
Answer: Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.
Q7. In cloning and mutagenesis market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cloning and mutagenesis market by product (cloning kits, mutagenesis kits, and others), technology (topo PCR cloning, blunt end cloning, seamless cloning, and others), end use (biopharmaceutical & pharmaceutical companies, CROs & CMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cloning And Mutagenesis Market, Cloning And Mutagenesis Market Size, Cloning And Mutagenesis Market Growth, Cloning And Mutagenesis Market Analysis, Cloning And Mutagenesis Market Report, Cloning And Mutagenesis Market Share, Cloning And Mutagenesis Market Trends, Cloning And Mutagenesis Market Forecast, Cloning And Mutagenesis Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Cloning and Mutagenesis Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cloning and Mutagenesis Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cloning and Mutagenesis Market by Product
3.3.1: Cloning Kits
3.3.2: Mutagenesis Kits
3.3.3: Others
3.4: Global Cloning and Mutagenesis Market by Technology
3.4.1: Topo PCR Cloning
3.4.2: Blunt end Cloning
3.4.3: Seamless Cloning
3.4.4: Others
3.5: Global Cloning and Mutagenesis Market by End Use
3.5.1: Biopharmaceutical & Pharmaceutical Companies
3.5.2: CROs & CMOs
3.5.3: Academic & Research Institutes
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Cloning and Mutagenesis Market by Region
4.2: North American Cloning and Mutagenesis Market
4.2.2: North American Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
4.3: European Cloning and Mutagenesis Market
4.3.1: European Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
4.3.2: European Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
4.4: APAC Cloning and Mutagenesis Market
4.4.1: APAC Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
4.4.2: APAC Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
4.5: ROW Cloning and Mutagenesis Market
4.5.1: ROW Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
4.5.2: ROW Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cloning and Mutagenesis Market by Product
6.1.2: Growth Opportunities for the Global Cloning and Mutagenesis Market by Technology
6.1.3: Growth Opportunities for the Global Cloning and Mutagenesis Market by End Use
6.1.4: Growth Opportunities for the Global Cloning and Mutagenesis Market by Region
6.2: Emerging Trends in the Global Cloning and Mutagenesis Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cloning and Mutagenesis Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cloning and Mutagenesis Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Takara Bio
7.2: Agilent Technologies
7.3: Thermo Fisher Scientific
7.4: New England Biolabs
7.5: Merck
7.6: Promega
7.7: Bio-Rad Laboratories
7.8: Danaher
7.9: Jena Bioscience
7.10: Assay Genie
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Cloning and Mutagenesis Market Report.